MolNFT v1 · #161532 · protein
Crystal structure of human kallikrein 6 in complex with GSK358180B
6QHC · Kallikrein-6: “Crystal structure of human kallikrein 6 in complex with GSK358180B”. X-ray diffraction, 1 ligand (135), 3 pockets (best druggability 0.70). MolNFT v1 #161532 on GenesisL1: 3D structure, binding sites and pockets in…
- PDB
- 6QHC
- Type
- protein
- Length
- 444 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Kallikrein-6
- EC
- 3.4.21.-
- UniProt
- Q92876
- Ligands
- 135
- Pockets
- 3 · best druggability 0.70
Structure
x-ray diffraction · 1 distinct chain · 10% helix, 38% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | Kallikrein-6 (EC 3.4.21.-) | protein | 222 | 10% helix, 38% strand | Q92876 |
Ligands and binding sites
- 135 · N-(4-carbamimidoyl-phenyl)-2-hydroxy-benzamide · ligand · 2 copies · chains A, B
- GOL · Glycerol · additive · chains A
- DMS · Dimethyl sulfoxide · additive · chains B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 577 | 0.70 | 0.79 | 54 | 135 |
| 2 | 54 | 0.53 | 0.88 | 21 | empty |
| 3 | 98 | 0.36 | 0.75 | 22 | 135 |
Interfaces
1 interface between chains.
- A–B · 489 Ų buried · 6 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 12 disulfide (disulfide).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q92876
- Elsewhere: RCSB PDB 6QHC · PDBe 6QHC · UniProt Q92876
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.